November 30, 2015
Recommended Topic Related To:


"The U.S. Food and Drug Administration today approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections.

Sivextro is approved to treat patients with acute bacterial skin and skin structure infecti"...




No Information Provided.


General: Not to be used when inflammation or exudation is present as increased absorption may occur.

Information for Patients:   See Warnings and Precautions section under Application Instructions.

Carcinogenesis:   Dermal application of 25% and 50% solutions of 2.5% selenium sulfide lotion on mice over an 88-week period indicated no carcinogenic effects.

Pregnancy:   WHEN USED FOR THE TREATMENT OF TINEA VERSICOLOR, SELSUN (selenium) IS CLASSIFIED AS PREGNANCY CATEGORY C. Animal reproduction studies have not been conducted with SELSUN (selenium) . It is also not known whether SELSUN (selenium) can cause fetal harm when applied to body surfaces of a pregnant woman or can affect reproduction capacity. Under ordinary circumstances SELSUN (selenium) should not be used for the treatment of tinea versicolor in pregnant women.

Pediatric Use:   Safety and effectiveness in infants have not been established.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 12/8/2004


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.